Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04408547
Other study ID # IakentroFC
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 3, 2014
Est. completion date December 30, 2019

Study information

Verified date May 2020
Source Iakentro Fertility Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Analysis our Embryo transfer data, prospectively collected during the last 6 years (2014- 2019), performed by the same operator YP, who has been doing embryo transfers since 1984. All factors that might impact the embryo transfer will be analyzed. We want to see which factors that influence the success rate are not related to the subjectivity of the operator and could be adjusted through different approaches.


Description:

Most patients undergoing IVF or ICSI reach a blastocyst embryo transfer but less achieve pregnancy and live birth. Many reasons have been proposed to explain these results. Among them, the factor Embryo Transfer Procedure gained less of the attention since few papers have been published and most of them had a lot of biases. In order to eliminate possible biases, we wanted to analyze our Embryo transfer data, prospectively collected during the last 6 years (2014- 2019), performed by the same operator YP, who has been doing embryo transfers since 1984. All factors that might impact the embryo transfer will be analyzed. We want to see which factors that influence the success rate are not related to the subjectivity of the operator and could be adjusted through different approaches.

Primary outcomes: bhCG positive rate, pregnancy rate, ongoing pregnancy rate, live birth rate.

Secondary outcomes: Full bladder, uterine ax orientation, Endometrial thickness, type of catheter, straightforward advancement of the preloaded catheter, use of a stiffer hard catheter to pass through the cervix and the orifice, the site of the uterine cavity that the embryo was released, single or double transfer due to blocked embryo in the catheter.

In addition for each embryo transfer variables that may influence the pregnancy rates will be collected: age of the woman, number of oocytes harvested, sperm characteristics, fertilization rate, stage and grade of the embryos the day of transfer


Recruitment information / eligibility

Status Completed
Enrollment 3512
Est. completion date December 30, 2019
Est. primary completion date December 30, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria:

- Women undergoing embryo transfer after IVF

Exclusion Criteria:

- Women with known embryo implantation issues

Study Design


Related Conditions & MeSH terms


Intervention

Device:
embryo transfer catheter
undergoing embryo transfer

Locations

Country Name City State
Greece IAKENTRO Fertility Center Thessaloniki

Sponsors (1)

Lead Sponsor Collaborator
Iakentro Fertility Centre

Country where clinical trial is conducted

Greece, 

References & Publications (1)

Prapas N, Prapas Y, Panagiotidis Y, Prapa S, Vanderzwalmen P, Makedos G. Cervical dilatation has a positive impact on the outcome of IVF in randomly assigned cases having two previous difficult embryo transfers. Hum Reprod. 2004 Aug;19(8):1791-5. Epub 200 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with bhCG positive test after embryo transfer Number of patients bhCG positive up to12 days after embryo transfer Number of patients bhCG positive up to12 days after embryo transfer
Primary Number of patients with on going clinical pregnancy Number of patients with on going clinical pregnancy up to12 weeks after embryo transfer Number of patients with on going clinical pregnancy up to 12 weeks after embryo transfer
Primary Number of live births after embryo transfer Number oflive birth up to9 months after embryo transfer Number oflive birth up to 9 months after embryo transfer
Secondary Percentage of fullnes of bladder Percentage of fullness of the bladder during embryo transfer At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Secondary Endometrial thickness Endometrial thickness prior to embryo transfer prior to embryo transfer
Secondary Uterine axe orientation Uterine axe orientation during embryo transfer At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Secondary Type of embryo transfer catheter Type of embryo transfer catheter used in the procedure At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Secondary Distance from the fundus of the embryo release Distance from the fundus of the embryo release At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Secondary Embryo retained in the catheter Embryo retained in the catheter Number of patients who underwent embryo transfer and the embryo was retained in the catheter at the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02528136 - The Clinical Carbetocin Myocardium Trial Phase 4